Found: 24
Select item for more details and to access through your institution.
Effect of Combining EGFR Tyrosine Kinase Inhibitors and Cytotoxic Agents on Cholangiocarcinoma Cells.
- Published in:
- Cancer Research & Treatment, 2021, v. 53, n. 2, p. 457, doi. 10.4143/crt.2020.585
- By:
- Publication type:
- Article
Untitled.
- Published in:
- Molecules, 2022, v. 27, n. 14, p. N.PAG, doi. 10.3390/molecules27144664
- By:
- Publication type:
- Article
Transcriptional Regulation of Cancer Immune Checkpoints: Emerging Strategies for Immunotherapy.
- Published in:
- Vaccines, 2020, v. 8, n. 4, p. 735, doi. 10.3390/vaccines8040735
- By:
- Publication type:
- Article
Sulfated Galactans from Red Seaweed Gracilaria fisheri Target EGFR and Inhibit Cholangiocarcinoma Cell Proliferation.
- Published in:
- American Journal of Chinese Medicine, 2017, v. 45, n. 3, p. 615, doi. 10.1142/S0192415X17500367
- By:
- Publication type:
- Article
Silencing of CD44 by siRNA suppressed invasion, migration and adhesion to matrix, but not secretion of MMPs, of cholangiocarcinoma cells.
- Published in:
- Clinical & Experimental Metastasis, 2011, v. 28, n. 8, p. 827, doi. 10.1007/s10585-011-9414-8
- By:
- Publication type:
- Article
NGAL knockdown by siRNA in human cholangiocarcinoma cells suppressed invasion by reducing NGAL/MMP-9 complex formation.
- Published in:
- Clinical & Experimental Metastasis, 2010, v. 27, n. 5, p. 295, doi. 10.1007/s10585-010-9327-y
- By:
- Publication type:
- Article
Molecularly Guided Drug Repurposing for Cholangiocarcinoma: An Integrative Bioinformatic Approach.
- Published in:
- Genes, 2022, v. 13, n. 2, p. 271, doi. 10.3390/genes13020271
- By:
- Publication type:
- Article
Receptor-interacting protein kinase 1 is a key mediator in TLR3 ligand and Smac mimetic-induced cell death and suppresses TLR3 ligand-promoted invasion in cholangiocarcinoma.
- Published in:
- Cell Communication & Signaling, 2020, v. 18, n. 1, p. 1, doi. 10.1186/s12964-020-00661-3
- By:
- Publication type:
- Article
Downregulation of ABCA1 and ABCG1 transporters by simvastatin in cholangiocarcinoma cells.
- Published in:
- Oncology Letters, 2019, v. 18, n. 5, p. 5173, doi. 10.3892/ol.2019.10874
- By:
- Publication type:
- Article
Gadd45β silencing impaired viability and metastatic phenotypes in cholangiocarcinoma cells by modulating the EMT pathway.
- Published in:
- Oncology Letters, 2018, v. 15, n. 3, p. 3031, doi. 10.3892/ol.2017.7706
- By:
- Publication type:
- Article
Inhibition of protein kinase C promotes dengue virus replication.
- Published in:
- Virology Journal, 2016, v. 13, n. 1, p. 1, doi. 10.1186/s12985-016-0494-6
- By:
- Publication type:
- Article
Bioinformatics and qPCR analyses of laminins’ cognate receptors in cholangiocarcinoma tissues reveal the integrin ITGB4 as a potential biomarker.
- Published in:
- ScienceAsia, 2022, v. 48, n. 4, p. 379, doi. 10.2306/scienceasia1513-1874.2022.049
- By:
- Publication type:
- Article
Novel Serum Biomarkers to Differentiate Cholangiocarcinoma from Benign Biliary Tract Diseases Using a Proteomic Approach.
- Published in:
- Disease Markers, 2015, p. 1, doi. 10.1155/2015/105358
- By:
- Publication type:
- Article
Targeting MYC at the intersection between cancer metabolism and oncoimmunology.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1324045
- By:
- Publication type:
- Article
Targeting FGFRs Using PD173074 as a Novel Therapeutic Strategy in Cholangiocarcinoma.
- Published in:
- Cancers, 2023, v. 15, n. 9, p. 2528, doi. 10.3390/cancers15092528
- By:
- Publication type:
- Article
Key necroptotic proteins are required for Smac mimetic-mediated sensitization of cholangiocarcinoma cells to TNF-α and chemotherapeutic gemcitabine-induced necroptosis.
- Published in:
- PLoS ONE, 2020, v. 15, n. 1, p. 1, doi. 10.1371/journal.pone.0227454
- By:
- Publication type:
- Article
Porcine placenta extract improves high-glucose-induced angiogenesis impairment.
- Published in:
- BMC Complementary Medicine & Therapies, 2021, v. 21, n. 1, p. 1, doi. 10.1186/s12906-021-03243-z
- By:
- Publication type:
- Article
Activation of cannabinoid receptors in breast cancer cells improves osteoblast viability in cancer-bone interaction model while reducing breast cancer cell survival and migration.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-11116-9
- By:
- Publication type:
- Article
Impairment of muscle function caused by mutations of phosphorylation sites in myosin regulatory...
- Published in:
- Nature, 1995, v. 374, n. 6523, p. 650, doi. 10.1038/374650a0
- By:
- Publication type:
- Article
Role of mTOR inhibitor in cholangiocarcinoma cell progression.
- Published in:
- Oncology Letters, 2014, v. 7, n. 3, p. 854, doi. 10.3892/ol.2014.1799
- By:
- Publication type:
- Article
CD24 induces the invasion of cholangiocarcinoma cells by upregulating CXCR4 and increasing the phosphorylation of ERK1/2.
- Published in:
- Oncology Letters, 2013, v. 6, n. 5, p. 1439, doi. 10.3892/ol.2013.1587
- By:
- Publication type:
- Article
CP-673451, a Selective Platelet-Derived Growth Factor Receptor Tyrosine Kinase Inhibitor, Induces Apoptosis in Opisthorchis viverrini -Associated Cholangiocarcinoma via Nrf2 Suppression and Enhanced ROS.
- Published in:
- Pharmaceuticals (14248247), 2024, v. 17, n. 1, p. 9, doi. 10.3390/ph17010009
- By:
- Publication type:
- Article
RTK25: A Comprehensive Molecular Profiling Strategy in Cholangiocarcinoma Using an Integrated Bioinformatics Approach.
- Published in:
- Pharmaceuticals (14248247), 2021, v. 14, n. 9, p. 898, doi. 10.3390/ph14090898
- By:
- Publication type:
- Article
Co-Clinical Trials: An Innovative Drug Development Platform for Cholangiocarcinoma.
- Published in:
- Pharmaceuticals (14248247), 2021, v. 14, n. 1, p. 51, doi. 10.3390/ph14010051
- By:
- Publication type:
- Article